BookYukihiro Takahashi.
Summary: This book demonstrates the significance of minimally invasive extracorporeal circulation and reduced time as two of the most important factors for pediatric cardiac surgery and early postoperative recovery. The content is divided into three major thematic sections: low invasiveness; pitfalls and countermeasures before, during and after operations; and suggestions on time saving and team building. Abundant figures aid in comprehension, while videos of the surgery offer practical insights for readers at all levels. Advances in extracorporeal circulation devices and management have led to new clinical problems such as decreased perfusion pressure, high pressures in oxygenators, and changes in acid-base equilibrium. The book explains these problems both clinically and experimentally, and describes countermeasures. Low Invasive Pediatric Cardiac Surgery provides valuable evidence and practical suggestions for all surgeons, perfusionists, scrub-nurses, and anesthesiologists who are engaged in pediatric cardiac surgery. It will also appeal to pediatric cardiologists and medical device manufacturers. The book is intended to share the authors experience and actual data with readers who have clinical experience, and to help prepare beginners. .
Contents:
Intro
Preface
Contents
About the Author
Part I: Extracorporeal Circulation and Low Invasiveness
1: Experience of Minimally Invasive Extracorporeal Circulation
1.1 Introduction
1.2 Implications of Invasion and Minimally Invasiveness in Cardiac Surgery
1.3 Extracorporeal Circulation Method for Minimally Invasive
1.4 History of Minimally Invasive Measures at Sakakibara Heart Institute
1.4.1 Establishment and Clinical Effect of Ultrafiltration Method
1.4.1.1 ECUM Effect in Infant VSD (1990) 1.4.1.2 ECUM Effect in Complete Atrioventricular Septal Defect (AVSD) (1992-1993)
1.4.2 Problems with Ultrafiltration
1.4.2.1 Protein Leakage (1991-1992)
1.4.2.2 Arrhythmia (1991-1993)
1.4.3 Advances in Ultrafiltration Methods
1.4.3.1 Measurement of Inflammatory Reactive Substances (1991-1993)
ECUM Only After the Start of Rewarming
Ultrafiltration During Aortic Cross-Clamp + During Rewarming
1.4.3.2 Measurement of Inflammatory Reactive Substances (1994-1995)
1.4.3.3 New Heart-Lung Machine and Inflammatory Reactive Substances (1997-1998) 1.5 Summary of Minimally Invasive
References
2: Development of Cardiopulmonary Bypass System and Devices Aiming for Minimally Invasive
2.1 Introduction
2.2 Development History
2.2.1 Low-Volume Oxygenator 1
2.2.2 Component Type Heart-Lung Machine
2.2.3 Low-Volume Oxygenator 2
2.2.4 Low-Volume Oxygenator 3
2.2.5 Isolated Pump-Controller Heart-Lung Machine 1
2.2.6 Low-Volume Oxygenator 4
2.2.7 Isolated Pump-Controller Heart-Lung Machine 2
2.2.8 Isolated Pump-Controller Heart-Lung Machine 3
2.2.9 The New Sakakibara Heart Institute 2.2.10 Transition of Priming Volume Reduction, Vacuum-Assisted Venous Drainage (VAVD)
2.2.11 Isolated Pump-Controller Heart-Lung Machine 4
2.2.12 Change in Priming Volume New Device
2.2.13 Current Priming Volume
2.3 Summary of Extracorporeal Circulation Devices
References
3: Advances in Bloodless Open-Heart Surgery
3.1 Introduction
3.2 Bloodless Open-Heart Surgery and Homologous Blood Transfusion
3.3 Bloodless Open-Heart Surgery for Acyanotic Congenital Heart Disease with Pulmonary Hypertension
3.3.1 1983-1992
3.3.2 1993
3.3.3 1994 3.3.4 Possibility of Bloodless Open-Heart Surgery for VSD Infant Weighing 4 kg (1995)
3.3.5 Bloodless Open-Heart Surgery in VSD Infants Weighing 3-4 kg (1997)
3.3.6 Bloodless Open-Heart Surgery for Complete AVSD: Comparison with VSD
3.3.7 Number of Blood Transfusions Used in Blood Priming Cases
3.4 Management and Measures for Bloodless Open-Heart Surgery in Low-Weight Infant
3.4.1 Determination of Indication for Bloodless Open-Heart Surgery
3.4.1.1 Indication Decision by Clinical Evaluation
3.4.1.2 Indication Decision by Hemodilution
3.4.2 Surgery
3.4.3 Anesthesia Management